Logiscreen

Dexcom Inc

$72.86
Market Cap 28.04B
ROE 33.8%
Gross Margin 62.9%
Debt/Equity 0.5
Current Ratio 1.9
Revenue QoQ 15.0%
EPS QoQ 0.9%
F-Score 8

About

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently. Category: IR

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Fair Value

Trading at a discount to sector peers

P/E
30.03
vs median 33.61
P/B
9.45
vs median 2.16
ROE
0.34
vs median 0.09

High quality company with strong fundamentals

Large-cap company with established market presence

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics